WuXi AppTec

Pharma

Astellas, Takeda, RA Capital—Fierce Pharma Asia

Astellas CEO lays out the firm's new five-year plan. Takeda beats BMS in a psoriasis trial. RA provides China capabilities to its portfolio. And more.

Angus Liu Jun 12, 2026 8:23am

WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban

Jun 9, 2026 12:24pm

WuXi Bio's contracting business saw influx of US clients in '25

Mar 24, 2026 10:56am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Biosecure Act slips into key US defense bill

Dec 9, 2025 11:00am

FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia

Dec 5, 2025 8:45am

WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg

Dec 4, 2025 8:55am